Skip to content 
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China. more
| Time Frame | CCM | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -6.27% | 0.72% | -1.31% |
| 1-Month Return | -11.36% | 1.27% | 0.78% |
| 3-Month Return | -12.01% | 3.13% | 3.46% |
| 6-Month Return | -32.46% | 15.81% | 6.19% |
| 1-Year Return | -23.85% | 8.89% | 11.68% |
| 3-Year Return | -69.58% | 20.79% | 71.21% |
| 5-Year Return | -91.86% | 35.89% | 74.81% |
| 10-Year Return | -92.55% | 138.44% | 256.59% |
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 223.01M | 485.63M | 472.08M | 537.40M | 383.96M | [{"date":"2020-12-31","value":41.5,"profit":true},{"date":"2021-12-31","value":90.37,"profit":true},{"date":"2022-12-31","value":87.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":71.45,"profit":true}] |
| Cost of Revenue | 209.93M | 542.53M | 624.49M | 614.01M | 463.12M | [{"date":"2020-12-31","value":33.62,"profit":true},{"date":"2021-12-31","value":86.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.32,"profit":true},{"date":"2024-12-31","value":74.16,"profit":true}] |
| Gross Profit | 13.08M | (56.90M) | (152.41M) | (76.61M) | (79.16M) | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-434.89,"profit":false},{"date":"2022-12-31","value":-1164.94,"profit":false},{"date":"2023-12-31","value":-585.55,"profit":false},{"date":"2024-12-31","value":-605.08,"profit":false}] |
| Gross Margin | 5.87% | (11.72%) | (32.28%) | (14.26%) | (20.62%) | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-199.71,"profit":false},{"date":"2022-12-31","value":-550.31,"profit":false},{"date":"2023-12-31","value":-242.99,"profit":false},{"date":"2024-12-31","value":-351.44,"profit":false}] |
| Operating Expenses | 320.58M | 401.42M | 372.64M | 386.38M | 453.00M | [{"date":"2020-12-31","value":70.77,"profit":true},{"date":"2021-12-31","value":88.61,"profit":true},{"date":"2022-12-31","value":82.26,"profit":true},{"date":"2023-12-31","value":85.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] |
| Operating Income | (307.50M) | (458.32M) | (525.05M) | (462.99M) | (532.16M) | [{"date":"2020-12-31","value":-30750100000,"profit":false},{"date":"2021-12-31","value":-45831800000,"profit":false},{"date":"2022-12-31","value":-52504800000,"profit":false},{"date":"2023-12-31","value":-46298500000,"profit":false},{"date":"2024-12-31","value":-53216000000,"profit":false}] |
| Total Non-Operating Income/Expense | (207.07M) | (138.81M) | (425.18M) | (247.45M) | (316.64M) | [{"date":"2020-12-31","value":-20707100000,"profit":false},{"date":"2021-12-31","value":-13881400000,"profit":false},{"date":"2022-12-31","value":-42518400000,"profit":false},{"date":"2023-12-31","value":-24744600000,"profit":false},{"date":"2024-12-31","value":-31663700000,"profit":false}] |
| Pre-Tax Income | (441.65M) | (529.24M) | (839.90M) | (555.59M) | (669.58M) | [{"date":"2020-12-31","value":-44165300000,"profit":false},{"date":"2021-12-31","value":-52923700000,"profit":false},{"date":"2022-12-31","value":-83989600000,"profit":false},{"date":"2023-12-31","value":-55559400000,"profit":false},{"date":"2024-12-31","value":-66958000000,"profit":false}] |
| Income Taxes | (37.62M) | (6.57M) | (70.91M) | (24.57M) | (17.50M) | [{"date":"2020-12-31","value":-3762400000,"profit":false},{"date":"2021-12-31","value":-656500000,"profit":false},{"date":"2022-12-31","value":-7090600000,"profit":false},{"date":"2023-12-31","value":-2457300000,"profit":false},{"date":"2024-12-31","value":-1750500000,"profit":false}] |
| Income After Taxes | (404.03M) | (522.67M) | (768.99M) | (531.02M) | (652.08M) | [{"date":"2020-12-31","value":-40402900000,"profit":false},{"date":"2021-12-31","value":-52267200000,"profit":false},{"date":"2022-12-31","value":-76899000000,"profit":false},{"date":"2023-12-31","value":-53102100000,"profit":false},{"date":"2024-12-31","value":-65207500000,"profit":false}] |
| Income From Continuous Operations | (404.03M) | (522.67M) | (768.99M) | (531.02M) | (652.08M) | [{"date":"2020-12-31","value":-40402900000,"profit":false},{"date":"2021-12-31","value":-52267200000,"profit":false},{"date":"2022-12-31","value":-76899000000,"profit":false},{"date":"2023-12-31","value":-53102100000,"profit":false},{"date":"2024-12-31","value":-65207500000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
| Net Income | (404.03M) | (271.43M) | (489.66M) | (297.66M) | (308.24M) | [{"date":"2020-12-31","value":-40402900000,"profit":false},{"date":"2021-12-31","value":-27142700000,"profit":false},{"date":"2022-12-31","value":-48966100000,"profit":false},{"date":"2023-12-31","value":-29765800000,"profit":false},{"date":"2024-12-31","value":-30824300000,"profit":false}] |
| EPS (Diluted) | (2.90) | (0.59) | - | - | - | [{"date":"2020-12-31","value":-290.2,"profit":false},{"date":"2021-12-31","value":-58.77,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| CCM | |
|---|---|
| Cash Ratio | 0.07 |
| Current Ratio | 0.42 |
| Quick Ratio | 0.41 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| CCM | |
|---|---|
| ROA (LTM) | -4.48% |
| ROE (LTM) | -29.03% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| CCM | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.74 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.33 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| CCM | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.04 |
| P/B | 3.00 |
| EV/R | 10.28 |
| EV/Ebitda | NM |
| PEG | NM |
Concord Medical Services Holdings (CCM) share price today is $3.61
Yes, Indians can buy shares of Concord Medical Services Holdings (CCM) on Vested. To buy
Yes, you can purchase fractional shares of Concord Medical Services Holdings (CCM) via the Vested app. You can start investing in Concord Medical Services Holdings (CCM) with a minimum investment of $1.
You can invest in shares of Concord Medical Services Holdings (CCM) via Vested in three simple steps:
The 52-week high price of Concord Medical Services Holdings (CCM) is $10. The 52-week low price of Concord Medical Services Holdings (CCM) is $3.49.
The price-to-earnings (P/E) ratio of Concord Medical Services Holdings (CCM) is
The price-to-book (P/B) ratio of Concord Medical Services Holdings (CCM) is 3.00
The dividend yield of Concord Medical Services Holdings (CCM) is 0.00%
The market capitalization of Concord Medical Services Holdings (CCM) is $15.59M
The stock symbol (or ticker) of Concord Medical Services Holdings is CCM
Consider the share price of Concord Medical Services Holdings as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Concord Medical Services Holdings has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Concord Medical Services Holdings shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Concord Medical Services Holdings stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Concord Medical Services Holdings and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Concord Medical Services Holdings stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
